Sheng Wang Tu
Director/Board Member at Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
Sheng Wang Tu active positions
| Companies | Position | Start | End |
|---|---|---|---|
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
 Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Director/Board Member | - | - |
Career history of Sheng Wang Tu
Statistics
International
| China | 2 |
Operational
| Director/Board Member | 1 |
Sectoral
| Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Process Industries |
- Stock Market
- Insiders
- Sheng Wang Tu
- Experience
